carbohydrazide has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, M; Ashfaq, UA; Taj, S | 1 |
| Ahmad, M; Ahmad, MN; Anjum, MN; Ashfaq, UA; Aslam, S; Mohsin, NA; Saddique, FA | 1 |
2 other study(ies) available for carbohydrazide and Diabetes Mellitus
| Article | Year |
|---|---|
Exploring of novel 4-hydroxy-2H-benzo[e][1,2]thiazine-3-carbohydrazide 1,1-dioxide derivative as a dual inhibitor of α-glucosidase and α-amylase: Molecular docking, biochemical, enzyme kinetic and in-vivo mouse model study.
Topics: alpha-Amylases; alpha-Glucosidases; Animals; Diabetes Mellitus; Glycoside Hydrolase Inhibitors; Hydrazines; Hyperglycemia; Hypoglycemic Agents; Mice; Molecular Docking Simulation; Molecular Dynamics Simulation; Thiazines | 2022 |
Alpha-glucosidase inhibition and molecular docking studies of 1,2-benzothiazine 1,1-dioxide based carbohydrazides.
Topics: Acarbose; alpha-Glucosidases; Diabetes Mellitus; Glycoside Hydrolase Inhibitors; Humans; Hydrazines; Hypoglycemic Agents; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship; Thiazines | 2019 |